share_log

Merck & Co | 4: Statement of changes in beneficial ownership of securities-Officer Romanelli Joseph

SEC announcement ·  Feb 15 07:02
Summary by Futu AI
Joseph Romanelli, President of Human Health International at Merck & Co., Inc., completed a sale of 1,000 shares of the company's common stock on February 13, 2024. The transaction was carried out on the open market with the shares sold at a price of $124.89 each, totaling approximately $124,888 in value. Following the sale, Romanelli's direct holdings in Merck & Co. amount to 19,569.325 shares. The sale reflects a transaction in the normal course of trading and is part of the regular financial activities of corporate executives.
Joseph Romanelli, President of Human Health International at Merck & Co., Inc., completed a sale of 1,000 shares of the company's common stock on February 13, 2024. The transaction was carried out on the open market with the shares sold at a price of $124.89 each, totaling approximately $124,888 in value. Following the sale, Romanelli's direct holdings in Merck & Co. amount to 19,569.325 shares. The sale reflects a transaction in the normal course of trading and is part of the regular financial activities of corporate executives.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1

The information provided by Futu AI is automatically generated by third-party artificial intelligence (AI) software based on news content. It is only available to users located outside of China mainland.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.